Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 92 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

8%

7 trials in Phase 3/4

Results Transparency

6%

2 of 31 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

66Total
Not Applicable (53)
P 1 (3)
P 2 (3)
P 3 (5)
P 4 (2)

Trial Status

Completed31
Recruiting28
Unknown22
Not Yet Recruiting6
Active Not Recruiting4
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (92)

Showing 20 of 20 trials
NCT04889924Not ApplicableRecruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

NCT07696754Not ApplicableNot Yet Recruiting

Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer

NCT07683572Not Yet Recruiting

Device Validation of Augmented-Reality ICG Fluorescence Imaging for Sentinel Lymph Node Detection in Breast Cancer

NCT07146295Not ApplicableRecruiting

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

NCT04109079Not ApplicableRecruiting

Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy

NCT04303715Not ApplicableActive Not Recruiting

No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography

NCT04073706Phase 3Recruiting

Sentinel Node Biopsy in Endometrial Cancer

NCT07362485Not ApplicableRecruiting

Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)

NCT04636710Not ApplicableRecruiting

Refining Local-Regional Therapy for IBC

NCT07303231Phase 3Not Yet Recruiting

The Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy

NCT06652672Not ApplicableRecruiting

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

NCT03097575Phase 1RecruitingPrimary

Bronchial NIR Image-guided Resection

NCT05763641RecruitingPrimary

TAD After Chemotherapy in Locally Advanced Breast Cancer

NCT07154563Recruiting

Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

NCT04826211Not ApplicableCompleted

Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI

NCT05774483Not ApplicableRecruiting

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

NCT07040657Not ApplicableRecruiting

Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue

NCT07018505Not Yet RecruitingPrimary

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

NCT06911528Not ApplicableRecruiting

Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer

NCT03123042Not ApplicableCompletedPrimary

Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection

Scroll to load more

Research Network

Activity Timeline